Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These receptors have a lower sensitivity to ACh compared with α4β2* nAChRs and also have varying channel properties based on subunit stoichiometry and composition.97”
From Nicotinic Acetylcholine Receptor Signaling in the Hypothalamus: Mechanisms Related to Nicotine’s Effects on Food Intake (2020) · cites this paper as [97]
In the citing paper
“Cytisine is a more efficient agonist of mouse β4* nAChRs than human β4* nAChRs, 97 making it a useful tool in identifying the role of β4* nAChRs in the mouse model system, but it is not effective in reducing long-term weight gain in human smokers.”
From Nicotinic Acetylcholine Receptor Signaling in the Hypothalamus: Mechanisms Related to Nicotine’s Effects on Food Intake (2020) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Habenular α5 nicotinic receptor subunit signalling controls nicotine intake
Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011) · Nature · doi:10.1038/nature09797 · Cited by 663 · cited 1×
“…confirmed to be expressed in autonomic ganglia (Wang et al., 2002), hippocampus (Sudweeks and Yakel, 2000) and the cortex (Han et al., 2000), as well as the particularly nAChR-rich brain structures of the medial habenula and interpeduncular nucleus (Fowler et al., 2011; Grady et al., 2009).”
Varenicline Is a Partial Agonist at α4β2 and a Full Agonist at α7 Neuronal Nicotinic Receptors
Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025130 · Cited by 558
Nicotine Decreases Food Intake Through Activation of POMC Neurons
Mineur, Y. S., Abizaid, A., Rao, Y., Salas, R., DiLeone, R. J., Gündisch, D., Diano, S., De Biasi, M., Horvath, T. L., Gao, X.-B., et al. (2011) · Science · doi:10.1126/science.1201889 · Cited by 439 · cited 4×
“However, as new roles are being discovered for these receptors in the CNS, in regard to nicotine use and appetite control (Mineur et al., 2011), it becomes important to characterize the a3b4 receptor subtypes and understand how to target them selectively.”
InfluentialSalas, R., Sturm, R., Boulter, J., & De Biasi, M. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.4934-08.2009 · Cited by 310 · cited 1×
“However, recent studies have also demonstrated a link between α3β4α5-containing receptors in the medial habenula and nicotine-related behavior, promoting receptors with combinations of these subunits as an alternative target for the development of smoking cessation drugs (Fowler et al., 2011; Frahm et al., 2011; Galle…”
Boulter, J., O'Shea-Greenfield, A., Duvoisin, R. M., Connolly, J. G., Wada, E., Jensen, A., Gardner, P. D., Ballivet, M., Deneris, E. S., & McKinnon, D. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39588-2 · Cited by 302
Frahm, S., Ślimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S., Filkin, S., Pons, S., Fontaine, J.-F., Tsetlin, V., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.04.013 · Cited by 283
Partial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259
Self-citationGrady, S. R., Moretti, M., Zoli, M., Marks, M. J., Zanardi, A., Pucci, L., Clementi, F., & Gotti, C. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5121-08.2009 · Cited by 222
Roles of Accessory Subunits in α4β2* Nicotinic Receptors
Kuryatov, A., Onksen, J., & Lindstrom, J. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046789 · Cited by 195 · cited 1×
“We found that nicotine responses were affected by the identity of the α3β4* structural subunits, as previously reported for α4β2* receptors (Kuryatov et al., 2008).”
Nicotinic Receptor Gene Variants Influence Susceptibility to Heavy Smoking
Stevens, V. L., Bierut, L. J., Talbot, J. T., Wang, J. C., Sun, J., Hinrichs, A. L., Thun, M. J., Goate, A., & Calle, E. E. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0585 · Cited by 190 · cited 1×
“The human α3-β4-α5 genes are in a cluster at chromosomal location 15q24, and recent genome-wide association studies indicated strong correlations between single nucleotide polymorphisms in the α3-β4-α5 gene cluster and risk for both cancer and nicotine dependence (Chen et al., 2009; Stevens et al., 2008).”
Human α4β2 Acetylcholine Receptors Formed from Linked Subunits
Zhou, Y., Nelson, M. E., Kuryatov, A., Choi, C., Cooper, J., & Lindstrom, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-27-09004.2003 · Cited by 174 · cited 2×
“…as that of β2, we followed the scheme of Zhou et al, 2003 (Zhou et al., 2003), and prepared the concatamer with, in sequence: β4 signal, mature β4, 6(AGS) linker, then α3 mature (without signal sequence), all in frame, which should assemble with the α3-β4 binding pocket intact (Zhou et al., 2003).”
Kuryatov, A., Berrettini, W., & Lindstrom, J. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.066357 · Cited by 171 · cited 1×
“In co-expression studies with α4–β2 concatamers, Lindstrom and co-workers (Kuryatov et al., 2011) found this mutant in α5 lowered the calcium permeability of the receptors compared to wild-type and may have also affected the receptor's kinetic properties.”
Rollema, H., Shrikhande, A., Ward, K., Tingley III, F., Coe, J., O'Neill, B., Tseng, E., Wang, E., Mather, R., Hurst, R., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00682.x · Cited by 162 · cited 2×
“and varenicline are agents presently in use as smoking cessation aids (Rollema et al., 2010).”
Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
Han, Z., Le Novère, N., Zoli, M., Hill, J. A., Champtiaux, N., & Changeux, J. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00262.x · Cited by 156 · cited 2×
“…α5 gene was subsequently confirmed to be expressed in autonomic ganglia (Wang et al., 2002), hippocampus (Sudweeks and Yakel, 2000) and the cortex (Han et al., 2000), as well as the particularly nAChR-rich brain structures of the medial habenula and interpeduncular nucleus (Fowler et al., 2011;…”
Jackson, K. J., Marks, M. J., Vann, R. E., Chen, X., Gamage, T. F., Warner, J. A., & Damaj, M. I. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.165738 · Cited by 156
Suicidal Behavior and Depression in Smoking Cessation Treatments
Moore, T. J., Furberg, C. D., Glenmullen, J., Maltsberger, J. T., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027016 · Cited by 150 · cited 2×
“effects for varenicline, while there have been fewer such reports for cytisine (Moore et al., 2011; Shytle et al., 2011).”
The Nicotinic Acetylcholine Receptor 5 Subunit Plays a Key Role in Attention Circuitry and Accuracy
Bailey, C. D. C., De Biasi, M., Fletcher, P. J., & Lambe, E. K. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2258-10.2010 · Cited by 146 · cited 2×
“It may be the case that the role of a5, in combinationwith a3 and b4 in the habenular/ interpeduncular circuit, accounts for the knockout phenotype related to nicotine associated behavior, while the phenotype associated with attentional performance may relate to receptors containing a4 and b2 in combination with a5 in…”
Research works printed but not linked: 19
- Chen, 2009, Variants in nicotinic acetylcholine receptors alpha5 and alpha3 increase risks to nicotine dependence, Am. J. Med. Genet. B Neuropsychiatr Genet., 150B, 926, 10.1002/ajmg.b.30919 · DOI · Paper page
- David, 2010, Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes, Eur. J. Neurosci., 31, 978, 10.1111/j.1460-9568.2010.07133.x · DOI
- Francis, 1998, Sensitivity to voltage-independent inhibition determined by pore-lining region of ACh receptor, Biophys. J., 74, 2306, 10.1016/S0006-3495(98)77940-8 · DOI
- Gallego, 2011, Overexpression of the CHRNA5/A3/B4 genomic cluster in mice increases the sensitivity to nicotine and modifies its reinforcing effects, Amino Acids
- Gerzanich, 1998, Alpha 5 subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors, J. Pharmacol. Exp. Ther., 286, 311
- Grinevich, 2005, Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit, J. Pharmacol. Exp. Ther., 312, 619, 10.1124/jpet.104.075069 · DOI
- Horenstein, 2008, Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors, Mol. Pharmacol., 74, 1496, 10.1124/mol.108.048892 · DOI
- Lape, 2008, On the nature of partial agonism in the nicotinic receptor superfamily, Nature, 454, 722, 10.1038/nature07139 · DOI · Paper page
- Li, 2011, Functional characterization of the alpha5(Asn398) variant associated with risk for nicotine dependence in the alpha3beta4alpha5 nicotinic receptor, Mol. Pharmacol., 80, 818, 10.1124/mol.111.073841 · DOI
- Miller, 1989, Genetic manipulation of ion channels: a new approach to structure and mechanism, Neuron, 2, 1195, 10.1016/0896-6273(89)90304-8 · DOI · Paper page
- Papke, 1993, The kinetic properties of neuronal nicotinic receptors: genetic basis of functional diversity, Prog. Neurobiol., 41, 509, 10.1016/0301-0082(93)90028-Q · DOI
- Papke, 2009, Tricks of Perspective: insights and limitations to the study of macroscopic currents for the analysis of nAChR activation and desensitization, J. Mol. Neurosci., 40, 77, 10.1007/s12031-009-9261-0 · DOI
- Papke, 2005, The effects of subunit composition on the inhibition of nicotinic receptors by the amphipathic blocker 2,2,6,6-tetramethylpiperidin-4-yl heptanoate, Mol. Pharmacol., 67, 1977, 10.1124/mol.105.011676 · DOI
- Papke, 2011, Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists, J. Pharmacol. Exp. Ther., 337, 367, 10.1124/jpet.110.177485 · DOI
- Papke, 2010, Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes, J. Pharmacol. Exp. Ther., 333, 501, 10.1124/jpet.109.164566 · DOI
- Ramirez-Latorre, 1996, Functional contributions of alpha5 subunit to neuronal acetylcholine receptor channels, Nature, 380, 347, 10.1038/380347a0 · DOI · Paper page
- Sudweeks, 2000, Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons, J. Physiol., 527, 515, 10.1111/j.1469-7793.2000.00515.x · DOI · Paper page
- Wang, 2002, The role of neuronal nicotinic acetylcholine receptor subunits in autonomic ganglia: lessons from knockout mice, Prog. Neurobiol., 68, 341, 10.1016/S0301-0082(02)00106-5 · DOI
- Wu, 2011, Naturally-expressed nicotinic acetylcholine receptor subtypes, Biochem. Pharmacol., 82, 800, 10.1016/j.bcp.2011.07.067 · DOI
Cited by
Calarco, C. A., & Picciotto, M. R. (2020) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz010 · Cited by 40
Calarco, C. A., Li, Z., Taylor, S. R., Lee, S., Zhou, W., Friedman, J. M., Mineur, Y. S., Gotti, C., & Picciotto, M. R. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13966 · Cited by 24
Metadata
- Authors
- Stokes, C., & Papke, R. L.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2012-09
- Volume
- 63
- Issue
- 4
- Pages
- 538-546
- ISSN
- 0028-3908
- Cited by
- 35
- References
- 17
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.